I

Inspien Inc
KOSDAQ:465480

Watchlist Manager
Inspien Inc
KOSDAQ:465480
Watchlist
Price: 3 640 KRW 4% Market Closed
Market Cap: ₩36.9B

Wall St Price Targets

Price Targets Summary
Inspien Inc

There are no price targets for Inspien Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Inspien Inc Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for Inspien Inc

Gross Profit
Forecast

17% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
17% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Inspien Inc

Operating Income
Forecast

-20% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-20% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Inspien Inc

Pre-Tax Income
Forecast

-30% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-30% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Inspien Inc

Net Income
Forecast

-27% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-27% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Inspien Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Inspien Inc's stock price target?
Not Available

Inspien Inc does not have any price targets made by Wall Street professionals.

Back to Top